Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Linke

Showing results (411-420 of 444) with videos related to

Pageof 45
Sort By:
The Lancet. Digital Health|January 29, 2022
Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trialAxel Bauer, Nikolay Sappler, Lukas von Stülpnagel, et al.
The New England Journal of Medicine|September 1, 2025
Long-Term Outcomes of the DanGer Shock TrialJacob E Møller, Rasmus P Beske, Thomas Engstrøm, et al.
European Journal of Heart Failure|January 17, 2025
Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shockAngela Dettling, Caroline Kellner, Jonas Sundermeyer, et al.
European Journal of Heart Failure|February 13, 2023
Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shockBenedikt Schrage, Jonas Sundermeyer, Benedikt Norbert Beer, et al.
European Heart Journal|February 8, 2017
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium InitiativeAlexandra J Lansky, Steven R Messé, Adam M Brickman, et al.
Journal of the American College of Cardiology|February 11, 2017
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium InitiativeAlexandra J Lansky, Steven R Messé, Adam M Brickman, et al.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
European Journal of Heart Failure|May 28, 2025
Kidney injury in patients with heart failure-related cardiogenic shock: Results from an international, multicentre cohort studyJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2023
Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shockJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary interventionPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Pageof 45

Showing results (411-420 of 444) with videos related to

Sort By:
Pageof 45
The Lancet. Digital Health|January 29, 2022
Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trialAxel Bauer, Nikolay Sappler, Lukas von Stülpnagel, et al.
The New England Journal of Medicine|September 1, 2025
Long-Term Outcomes of the DanGer Shock TrialJacob E Møller, Rasmus P Beske, Thomas Engstrøm, et al.
European Journal of Heart Failure|January 17, 2025
Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shockAngela Dettling, Caroline Kellner, Jonas Sundermeyer, et al.
European Journal of Heart Failure|February 13, 2023
Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shockBenedikt Schrage, Jonas Sundermeyer, Benedikt Norbert Beer, et al.
European Heart Journal|February 8, 2017
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium InitiativeAlexandra J Lansky, Steven R Messé, Adam M Brickman, et al.
Journal of the American College of Cardiology|February 11, 2017
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium InitiativeAlexandra J Lansky, Steven R Messé, Adam M Brickman, et al.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
European Journal of Heart Failure|May 28, 2025
Kidney injury in patients with heart failure-related cardiogenic shock: Results from an international, multicentre cohort studyJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2023
Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shockJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary interventionPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Pageof 45